January 20, 2015

Teva Pharmaceutical on Tuesday announced the U.S. Supreme Court’s decision in Teva Pharmaceuticals USA vs. Sandoz et al. that reversed the Federal Circuit Court’s judgment of invalidity of Teva’s ‘808 patent for Copaxone (glatiramer acetate injection) 20 mg/mL.

January 16, 2015

A report published in the Jan. 16 Morbidity and Mortality Weekly Report estimates that getting a flu vaccine this season reduced a person’s risk of having to go to the doctor because of flu by 23% among people of all ages.

January 16, 2015

AbbVie announced that the Food and Drug Administration has approved its Duopa (carbidopa and levodopa) enteral suspension, which is used to treat motor fluctuations for people with advanced Parkinson's disease. 

 

January 15, 2015

Marsh Supermarkets announced a Cardiac Care Program within their 39 pharmacy locations throughout Indiana. 

January 14, 2015

Egalet Corp. last week announced the licensing and acquisition of two pain products. Egalet has agreed to license worldwide rights to Oxaydo (oxycodone HCI, USP) tablets for oral use only -CII, the first and only approved immediate-release oxycodone product formulated to deter abuse via snorting from Acura Pharmaceuticals, the company stated.

January 14, 2015

The Food and Drug Administration established the Office of Pharmaceutical Quality, a new division tasked with improving quality control at pharmaceutical manufacturing facilities.

 

January 14, 2015

Ferndale Healthcare, distributor and marketer of RectiCare (Lidocaine 5%) anorectal cream, on Wednesday announced it is continuing its partnership with the Colon Cancer Alliance in 2015.

January 13, 2015

The flu is beginning to proliferate across the West, according to the latest Walgreens Flu Index report released Tuesday. 

January 12, 2015

AmerisourceBergen on Monday acquired MWI Veterinary Supply, the leading animal health distribution company in the United States, for $2.5 billion.

January 12, 2015

Halfway through the 2014-15 flu season, the Centers for Disease Control and Prevention reported that antiviral medications are being underutilized. 

January 12, 2015

In a first-of-its-kind randomized clinical trial, researchers from the Centre for Addiction and Mental Health and collaborators have shown the benefits of a personalized approach to smoking treatment, based on how quickly smokers break down nicotine in their bodies.

January 9, 2015

Influenza activity is becoming more prevalent the Centers for Disease Control and Prevention reported Friday, tracking influenza-like activity for the week ended Jan. 3. 

January 9, 2015

Daiichi Sankyo Co., Limited on Friday announced that the Food and Drug Administration has approved Savaysa (edoxaban) tablets, an oral, once-daily selective factor Xa-inhibitor that reduces the risk of stroke and systemic embolism in patients with non-valvular atrial fibrillation. 

 

January 8, 2015

Impax Pharmaceuticals on Thursday announced that the U.S. Food and Drug Administration approved Rytary, an extended-release oral capsule formulation of carbidopa-levodopa, for the treatment of Parkinson's disease.

January 7, 2015

Researchers at the University of North Carolina at Chapel Hill and North Carolina State University have uncovered a novel approach to creating inhalable vaccines using nanoparticles that shows promise for targeting such lung-specific diseases as influenza, pneumonia and tuberculosis.

January 6, 2015

According to the Walgreens Flu Index for the week beginning Jan. 5, Knoxville, Tenn. is the No. 1 designated market area with flu activity, followed by the Paducah, Ky. area and Chattanooga, Tenn.

January 5, 2015

About half the country is experiencing high levels of flu activity.

 

January 5, 2015

Keryx Biopharmaceuticals last month announced it has begun shipping Auryxia (ferric citrate) tablets to wholesalers in the United States. 

December 29, 2014

Actavis and Adamas Pharmaceuticals last week announced that the Food and Drug Administration approved Namzaric. According to the companies, the drug is used to treat moderate to severe dementia of the Alzheimer's type in patients stablized on memantine hydrochloride and donepezil hydrochloride.

 

December 29, 2014

Novo Nordisk last week announced that the Food and Drug Administration approved the company's new drug application for Saxenda, a once-daily glucagon-like peptide-1 receptor agonist used as an adjunct to a reduced-calorie diet and increased physical activity for weight management in adults.

December 29, 2014

Genentech last week announced that the Food and Drug Administration approved a supplemental biologics license application for Gazyva to be used in combination with chlorambucil chemotherapy in people with previously untreated chronic lymphocytic leukemia.

December 19, 2014

The overwhelming majority of GlaxoSmithKline shareholders on Thursday approved the proposed transaction with Novartis.

December 19, 2014

Teva Pharmaceutical announced that the Food and Drug Administration approved QNasl (beclomethasone dipropionate) 40 mcg for the treatment of nasal symptoms associated with allergic rhinitis in children ages 4 years to 11 years.

December 18, 2014

The Pharmaceutical Research and Manufacturers of America on Thursday released a new report, “Twenty-Five Years of Progress Against Hepatitis C: Setbacks and Stepping Stones."